REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmanuclear S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharmanuclear S A S Profile Updated: May 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Pharmanuclear S A S is a company in Colombia, with a head office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on October 01, 2009. The total number of employees is currently 5 (2024). From the latest financial highlights, Pharmanuclear S A S reported a net sales revenue increase of 39.08% in 2023. There was a total growth of 95.71% in Pharmanuclear S A S’s total assets over the same period. The net profit margin of Pharmanuclear S A S decreased by 0.81% in 2023.

Headquarters
Diagonal 24C # 99 - 60
Bogota D.C.; Bogota D.C; Postal Code: 0703

Contact Details: Purchase the Pharmanuclear S A S report to view the information.

Basic Information
Total Employees:
Purchase the Pharmanuclear S A S report to view the information.
Outstanding Shares:
Purchase the Pharmanuclear S A S report to view the information.
Incorporation Date:
October 01, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Pharmanuclear S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
39.08%
Total operating revenue
39.02%
Operating profit (EBIT)
35.48%
Net Profit (Loss) for the Period
32.03%
Total assets
95.71%
Total equity
82.07%
Operating Profit Margin (ROS)
-0.64%
Net Profit Margin
-0.81%
Return on Equity (ROE)
-17.09%
Quick Ratio
-4.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?